599 related articles for article (PubMed ID: 22823866)
41. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.
Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Zhang W; Zang FC
Behav Brain Res; 2012 Nov; 235(1):1-6. PubMed ID: 22828014
[TBL] [Abstract][Full Text] [Related]
42. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.
Dragicevic N; Copes N; O'Neal-Moffitt G; Jin J; Buzzeo R; Mamcarz M; Tan J; Cao C; Olcese JM; Arendash GW; Bradshaw PC
J Pineal Res; 2011 Aug; 51(1):75-86. PubMed ID: 21355879
[TBL] [Abstract][Full Text] [Related]
43. Oriental medicine Jangwonhwan reduces Abeta(1-42) level and beta-amyloid deposition in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
Seo JS; Yun JH; Baek IS; Leem YH; Kang HW; Cho HK; Lyu YS; Son HJ; Han PL
J Ethnopharmacol; 2010 Mar; 128(1):206-12. PubMed ID: 20079417
[TBL] [Abstract][Full Text] [Related]
44. Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer's disease after chronic exposure to aluminum.
Garcia T; Esparza JL; Nogués MR; Romeu M; Domingo JL; Gómez M
Hippocampus; 2010 Jan; 20(1):218-25. PubMed ID: 19405147
[TBL] [Abstract][Full Text] [Related]
45. Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.
O'Neal-Moffitt G; Delic V; Bradshaw PC; Olcese J
Mol Neurodegener; 2015 Jul; 10():27. PubMed ID: 26159703
[TBL] [Abstract][Full Text] [Related]
46. Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease.
Zilberter M; Ivanov A; Ziyatdinova S; Mukhtarov M; Malkov A; Alpár A; Tortoriello G; Botting CH; Fülöp L; Osypov AA; Pitkänen A; Tanila H; Harkany T; Zilberter Y
J Neurochem; 2013 Apr; 125(1):157-71. PubMed ID: 23241062
[TBL] [Abstract][Full Text] [Related]
47. Deficits in aversive but not in safe taste memory in the APPswe/PS1dE9 mice.
Ramírez-Lugo L; Jensen MS; Søderman A; West MJ
J Alzheimers Dis; 2009; 18(2):281-93. PubMed ID: 19584428
[TBL] [Abstract][Full Text] [Related]
48. Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease.
Pietropaolo S; Feldon J; Yee BK
Behav Neurosci; 2008 Aug; 122(4):733-47. PubMed ID: 18729626
[TBL] [Abstract][Full Text] [Related]
49. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1δE9-deleted transgenic mice model of ß-amyloidosis.
Volianskis A; Køstner R; Mølgaard M; Hass S; Jensen MS
Neurobiol Aging; 2010 Jul; 31(7):1173-87. PubMed ID: 18790549
[TBL] [Abstract][Full Text] [Related]
50. Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) mice.
Knight EM; Brown TM; Gümüsgöz S; Smith JC; Waters EJ; Allan SM; Lawrence CB
Dis Model Mech; 2013 Jan; 6(1):160-70. PubMed ID: 22864021
[TBL] [Abstract][Full Text] [Related]
51. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
52. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H
Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567
[TBL] [Abstract][Full Text] [Related]
53. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy.
Miettinen R; Riedel A; Kalesnykas G; Kettunen HP; Puoliväli J; Soininen H; Arendt T
J Chem Neuroanat; 2005 Oct; 30(2-3):105-18. PubMed ID: 16081247
[TBL] [Abstract][Full Text] [Related]
54. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.
Feng Z; Qin C; Chang Y; Zhang JT
Free Radic Biol Med; 2006 Jan; 40(1):101-9. PubMed ID: 16337883
[TBL] [Abstract][Full Text] [Related]
55. Intracerebroventricular transplantation of human amniotic epithelial cells ameliorates spatial memory deficit in the doubly transgenic mice coexpressing APPswe and PS1ΔE9-deleted genes.
Xue SR; Chen CF; Dong WL; Hui GZ; Liu TJ; Guo LH
Chin Med J (Engl); 2011 Sep; 124(17):2642-8. PubMed ID: 22040417
[TBL] [Abstract][Full Text] [Related]
56. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease.
Pugh PL; Richardson JC; Bate ST; Upton N; Sunter D
Behav Brain Res; 2007 Mar; 178(1):18-28. PubMed ID: 17229472
[TBL] [Abstract][Full Text] [Related]
57. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
58. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.
Cheng D; Spiro AS; Jenner AM; Garner B; Karl T
J Alzheimers Dis; 2014; 42(4):1383-96. PubMed ID: 25024347
[TBL] [Abstract][Full Text] [Related]
59. Dysregulated clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in amyloid precursor protein transgenic mice.
Fusilier AR; Davis JA; Paul JR; Yates SD; McMeekin LJ; Goode LK; Mokashi MV; Remiszewski N; van Groen T; Cowell RM; McMahon LL; Roberson ED; Gamble KL
Neurobiol Dis; 2021 Oct; 158():105454. PubMed ID: 34333153
[TBL] [Abstract][Full Text] [Related]
60. A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease.
He P; Ouyang X; Zhou S; Yin W; Tang C; Laudon M; Tian S
Horm Behav; 2013 Jun; 64(1):1-7. PubMed ID: 23651610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
